Results 91 to 100 of about 3,866,464 (201)

Diagnostic value of a serum four-biomarker panel for atrophic gastritis in women under 60 years of age

open access: yesFrontiers in Medicine
BackgroundWhile endoscopy is considered the gold standard for diagnosing chronic atrophic gastritis (CAG), serum biomarkers such as pepsinogen I (PG1), pepsinogen Ⅱ (PG2), the PGⅠ/PGⅡ ratio, and gastrin-17 (G-17) have been investigated for their ...
Wenqiao Jia, Wei Han
doaj   +1 more source

Gastrin receptors on nonparietal cells isolated from canine fundic mucosa

open access: yes, 1984
The cellular localization of gastrin receptors was studied using dispersed canine fundic mucosal cells. In previous studies 125I-[Leu15]gastrin-17 (125I-[Leu15]G-17) binding was found to parietal cells, but gastrin binding was also found in the small ...
L. P. Thomas   +6 more
core   +1 more source

Mucosal gastrin receptor. III. Regulation by gastrin

open access: yes, 1980
Specific binding of 125I-labeled gastrin to rat gastric mucosal membranes was found to vary with serum gastrin levels. The dissociation equilibrium constants were not significantly different between receptor preparations. However, the binding capacities
L. R. Johnson, G. R. Speir, K. Takeuchi
core   +1 more source

The metabolism of gastrin-52 and gastrin-6 in pigs

open access: yes, 2000
The kinetics and metabolism in various organs of three bioactive products of progastrin, the small sulfated and nonsulfated gastrin-6 and the large nonsulfated gastrin-52, were examined during intravenous administration in anesthetized pigs.
C. Palnæs Hansen   +3 more
core   +1 more source

Malignant transformation of gastric hyperplastic polyps in an autoimmune gastritis patient—a case report and literature review

open access: yesFrontiers in Medicine
The cancer risk in autoimmune gastritis (AIG) remains controversial. Malignant transformation of gastric hyperplastic polyps (GHPs) in an AIG patient is rare.
Yingqi Wang   +7 more
doaj   +1 more source

Evaluation of pepsinogen a and gastrin-17 as markers of gastric cancer and high-risk pathologic conditions

open access: yes, 1994
Background: Gastric cancer remains a major cause of mortality and will remain so for the lifetime of current clinicians. Many cancers are diagnosed at a stage when current therapy cannot provide the hope of cure.
Dunn, Janet A.   +2 more
core   +1 more source

Effects of Infection with Different Types of Helicobacter pylori on Gastric Secretion Function: A Cross-Sectional Clinical Study

open access: yesInternational Journal of General Medicine
Jinglei Wang,1 Dehong Qiao,2 Yunzhu Wang,3 Rui Xiong,1 Xinyi Ding,1 Wei Zhang,3 Tingting Wang,1 Kai Tang1 1Department of Gastroenterology, Zhejiang Rongjun Hospital, Jiaxing, People’s Republic of China; 2Minimally Invasive Diagnosis and Treatment Center,
Wang J   +7 more
doaj  

New Developments of Gastric Cancer Biomarker Research

open access: yesNano Biomedicine and Engineering, 2016
Gastric cancer is a deadly disease with high incidence and mortality rate in China. Early detection and treatment of gastric cancer showed significantly better 5-year survival rate.
Hualin Fu
doaj   +1 more source

Protective action of gastrin-17 against alcohol-induced gastric injury in the rat: role in mucosal defense

open access: yes, 1997
Exogenous cholecystokinin (CCK) or exposure of the stomach to the mild irritant 25% ethanol can prevent gastric injury. Ingestion of ethanol also elicits the release of CCK as well as gastrin, which is structurally similar to CCK.
D. W. Mercer   +3 more
core   +1 more source

Oral tolerogenic vaccine combined with gastrin restores immune tolerance and beta-cell function in NOD mice with Type 1 diabetes

open access: yesFrontiers in Immunology
Background and objectiveType 1 diabetes (T1D) results from autoimmune destruction of pancreatic β-cells. Current therapies fail to address the multiple mechanisms driving disease progression.
Jacob Cobb   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy